The Global Hypoglycemic Drugs Market To Show Strong Growth Accelerated By Increased Adoption Of Novel Drugs

 
Hypoglycemic Drugs Market 

Hypoglycemic drugs are medication used to treat high blood sugar levels, or hyperglycemia. These helps control blood glucose levels in patients with diabetes so they remain within the normal range.

The global Hypoglycemic Drugs Market is estimated to be valued at US$ 720.72 Mn in 2023 and is expected to exhibit a CAGR of 9.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rise in adoption of novel hypoglycemic drugs such as Semaglutide that combines GLP-1 and GIP receptors agonism in a single molecule for better glycemic control is expected to fuel the market growth over the forecast period. Furthermore, strong pipeline of emerging oral and injectables drugs alongside rising patient pool of diabetes globally is estimated to propel the demand for hypoglycemic drugs over the next few years.


Segment Analysis
The global hypoglycemic drugs market is dominated by oral hypoglycemic drugs segment due to high preference for oral drug administration among patients. The oral hypoglycemic drugs segment accounted for over 60% share in 2023 owing to the convenience of oral dosage forms and ease of at-home administration. However, the injectable hypoglycemic drugs segment is expected to witness fastest growth during the forecast period owing to the better efficacy of insulin and GLP-1 analogs in controlling blood sugar levels.

Key Takeaways

The Global Hypoglycemic Drugs Market Size  is expected to witness high growth at a CAGR of 9.2% during the forecast period of 2023 to 2030. The market size is projected to reach US$ 720.72 Mn in 2023.

Regional analysis
North America accounted for the largest share of over 35% in the global hypoglycemic drugs market in 2023. This is attributed to the growing prevalence of diabetes and rapid adoption of new drug therapies in the region. However, Asia Pacific is poised to witness fastest growth during the forecast period supported by rising geriatric population, growing obesity, and improving healthcare infrastructure in emerging countries.

Key players
Key players operating in the hypoglycemic drugs market are Eli Lilly & Company, Boehringer Ingelheim GmbH, Vistin Pharma AS, Janssen Pharmaceutica NV, Sanofi, Astellas Pharma Inc., AstraZeneca plc., Merck & Co., Inc., Novartis AG., Novo Nordisk A/S, Teva Pharmaceuticals Pvt Ltd., and Sun Pharmaceutical Industries Ltd. Eli Lilly & Company and Novo Nordisk A/S are the leading players in the global market owing to their diverse product portfolios and strong geographical presence.

 

Get more insights on this topic:

https://www.marketwebjournal.com/hypoglycemic-drugs-market-trends-size-and-share-analysis/

Comments

Post a Comment

Popular posts from this blog

Cellulose Films is the largest segment driving the growth of Cellulose Plastics Market

Image
  Cellulose Plastics Market The global Cellulose Plastics Market is estimated to be valued at US$ 819.69 Mn or Million in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: Cellulose plastics are bioplastics made from cellulose, one of the most abundant organic polymer on Earth. They are produced from plant materials like wood and agricultural residues. Cellulose plastics offer advantages like biodegradability, recyclability and sustainability. They are widely used in agriculture films, food packaging and textiles. Market key trends: One of the key trend in the cellulose plastics market is growing demand for biodegradable and sustainable packaging solutions. Rising environmental concerns regarding widespread use of conventional plastics is driving the demand for eco-friendly cellulose plastics. Strict government regulations prohibiting use of single use plast
Read more

Electronic Warfare Market Poised to Witness High Growth Owing to Increasing Usage of EW Systems Across Military and Defense Sectors

Image
Electronic Warfare Market Electronic warfare (EW) systems are used for detecting, deceiving or damaging enemy’s communication and radar systems. It involves deliberate emission or suppression of electromagnetic energy to maintain information dominance. EW systems find wide applications across military, including land, sea, air and space operations for counteracting threats from armed forces of other nations. The need for situational awareness and gaining tactical advantage over opponents has catalyzed demand from armed forces globally. The global electronic warfare market is estimated to be valued at US$ 18.45 Bn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2031.  Key players operating in the electronic warfare market are BAE Systems plc, Elbit Systems Ltd., General Dynamics Corporation, Israel Aerospace Industries Ltd., L3Harris Technologies Inc., Leonardo SpA, Lockheed Martin Corporation, Northrop Grumman Corporation, Raytheon Technologies Corpor
Read more

Eyewear Market Is Estimated To Witness High Growth Owing To the Growing Demand for Prescription Eyewear

Image
  Eyewear Market The global Eyewear Market is estimated to be valued at US$ 273.4 billion in 2018 and is expected to exhibit a CAGR of 6.0% over the forecast period 2023-2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: The Eyewear Market includes products such as prescription glasses, contact lenses, and sunglasses. These products offer vision correction and protection from harmful ultraviolet (UV) rays. The increasing prevalence of eye disorders and the growing awareness about the importance of eye health are driving the demand for eyewear products. Furthermore, the rising use of digital devices and exposure to blue light is also contributing to the need for prescription eyewear to reduce eye strain and prevent vision problems. Market Key Trends: One key trend in the Eyewear Market is the increasing demand for fashionable and luxury eyewear. Consumers are not only seeking vision correction but also looking for eyewear that complements
Read more